Showing results (131-140 of 5,040) with videos related to

Sort By:
Pageof 504
Multiple Sclerosis and Related Disorders|March 25, 2022
Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patientsHamza Mahmood Bajwa, Frederik Novak, Anna Christine Nilsson, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic reviewChumpol Anamnart, Nanthaya Tisavipat, Weerapat Owattanapanich, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, IranFardin Faraji, Farzane Ahmadi, Pegah Mohaghegh, et al.
Multiple Sclerosis and Related Disorders|September 19, 2018
Clinical utility of anti-MOG antibody testing in a Danish cohortViktoria Papp, Annika R Langkilde, Morten Blinkenberg, et al.
Multiple Sclerosis and Related Disorders|January 9, 2023
Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide studyPer Soelberg Sorensen, Luigi Pontieri, Hanna Joensen, et al.
Multiple Sclerosis and Related Disorders|January 13, 2023
Appointment attendance behaviors in multiple sclerosis: Understanding the factors that differ between no shows, short notice cancellations, and attended appointmentsElizabeth S Gromisch, Sarah A Raskin, Lindsay O Neto, et al.
Multiple Sclerosis and Related Disorders|December 18, 2022
Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in SwedenFitsum Sebsibe Teni, Alejandra Machado, Chantelle Murley, et al.
Multiple Sclerosis and Related Disorders|January 5, 2023
The concentrations of antibodies to Epstein-Barr virus decrease during ocrelizumab treatmentH Phuong T Pham, Sepideh Saroukhani, J William Lindsey
Multiple Sclerosis and Related Disorders|January 5, 2023
The relationship between severity of overactive bladder symptoms and cognitive dysfunction, anxiety and depression in female patients with multiple sclerosis: Running head: OAB-V8, BICAMS and HAD scale in MSYeşim Akkoç, Ayşe Nur Bardak, Necmettin Yıldız, et al.
Multiple Sclerosis and Related Disorders|January 5, 2023
Safety of inactivated COVID-19 vaccines in autoimmune encephalitis: A real-world cross-sectional surveyXu Liu, Kundian Guo, Lu Lu, et al.
Pageof 504